Gelteq (GELS) Change in Cash (2023 - 2025)
Gelteq's (GELS) quarterly Change in Cash came in at -$21.3 million in Q4 2025, down 11891.12% quarter-over-quarter from -$177355.8 in Q4 2023.
Gelteq (GELS) Change in Cash (2023 - 2025) Analysis & Trends
Gelteq's Change in Cash history runs 2 years deep, the most recent figure standing at -$21.3 million for Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -117.00 Mn |
| 10 | Gelteq | 740.00 | -47,821.64 | - | -21.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -21.27 Mn |
| Dec 31, 2023 | -177,355.85 |